Literature DB >> 17882576

Expression of uteroglobin in a murine model of allergic rhinitis.

Tae-Bin Won1, Song-Hua Quan, Chae-Seo Rhee, Yang-Gi Min, Chul Hee Lee.   

Abstract

CONCLUSION: We observed for the first time the expression of Uteroglobin (UGB) in the nasal mucosa of mice. The results of our study suggest that UGB may play an important role in the regulation of inflammation in allergic rhinitis (AR) as well as in the lower airway allergic inflammations.
OBJECTIVES: Uteroglobin is a protein secreted by epithelial lining of organs communicating with the external environment. Reports of its immunomodulatory effects in allergic disease have been made, but the true physiological role still remains to be elucidated. In this study we tried to observe the expression of UGB in the nasal mucosa of mice and determine its role in AR.
MATERIALS AND METHODS: Thirty BALB-c mice at 3 weeks of age (10 mice/group) were sensitized systemically by intraperitoneal ovalbumin injection and locally by ovalbumin inhalation. Control group were sensitized with PBS. Treatment group had intraperitoneal dexamethasone injection 1 hour before the initial sensitization while control and AR group were injected with PBS. Symptom scores, eosinophil counts, immunohistochemical staining as well as UGB mRNA expression in the nasal mucosa and lung tissue were analyzed.
RESULTS: The symptom scores and eosinophil counts between control and treatment group was significantly different from the AR group (P<0.01). On immunohistochemical staining, UGB was localized in the epithelium and submucosal gland of the nasal mucosa as well as in the epithelium of respiratory bronchioles. UGB mRNA expression of the nasal mucosa and lung tissue was decreased in the AR group compared to the control group (P=0.022). In the treatment group UGB expression was increased compared to the AR group (P=0.016). The results of IHC and mRNA expression in the lung tissue correlated with the results in the nasal mucosa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17882576     DOI: 10.1080/03655230701624921

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  4 in total

1.  Recombinant rat CC16 protein inhibits LPS-induced MMP-9 expression via NF-κB pathway in rat tracheal epithelial cells.

Authors:  Min Pang; Hailong Wang; Ji-Zhong Bai; Dawei Cao; Yi Jiang; Caiping Zhang; Zhihong Liu; Xinri Zhang; Xiaoyun Hu; Jianying Xu; Yongcheng Du
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-24

2.  Exogenous interleukin-10 alleviates allergic inflammation but inhibits local interleukin-10 expression in a mouse allergic rhinitis model.

Authors:  Shui-Bin Wang; Yu-Qin Deng; Jie Ren; Bo-Kui Xiao; Zheng Liu; Ze-Zhang Tao
Journal:  BMC Immunol       Date:  2014-02-25       Impact factor: 3.615

3.  Recombinant CC16 protein inhibits the production of pro-inflammatory cytokines via NF-κB and p38 MAPK pathways in LPS-activated RAW264.7 macrophages.

Authors:  Min Pang; Yangyang Yuan; Dong Wang; Ting Li; Dan Wang; Xiaohong Shi; Min Guo; Chunfang Wang; Xinri Zhang; Guoping Zheng; Baofeng Yu; Hailong Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2017-05-01       Impact factor: 3.848

4.  A Novel Strategy for the Treatment of Allergic Rhinitis: Regulating Treg/Th17 and Th1/Th2 Balance In Vivo by Vitamin D.

Authors:  Baowei Li; Xiaoli Zhang; Zhezhe Sun; Bingxin Xu; Jihua Wu; Hongdan Liu; Haolun Han; Lei Wang; Wei Wu
Journal:  Comput Math Methods Med       Date:  2022-07-31       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.